Novartis’s big wager on RNAi approaches the finish line

Novartis’s big wager on RNAi approaches the finish line

Submitted by admin on November 25, 2020 - 10:27am
Source: 
EP Vantage
News Tags: 
Novartis
RNAi
COVID-19
Leqvio
cholesterol
Headline: 
Novartis’s big wager on RNAi approaches the finish line
snippet: 

The Covid-19 pandemic might yet delay US approval of Novartis's cholesterol-lowering project Leqvio − and then come the commercial questions.

Do Not Allow Advertisers to Use My Personal information